Financial Performance - Revenue for Q3 2024 reached 203,976,000,a21168,569,000 in Q3 2023[16] - Gross profit for Q3 2024 was 104,834,000,comparedto88,514,000 in Q3 2023, reflecting an 18% growth[16] - Net income attributable to ACM Research, Inc. for Q3 2024 was 30,904,000,upfrom25,679,000 in Q3 2023, representing a 20% increase[16] - Basic net income per share for Q3 2024 was 0.49,upfrom0.43 in Q3 2023, a 14% increase[16] - Net income for the nine months ended September 30, 2024, was 92,163,000,anincreasefrom73,554,000 for the same period in 2023, representing a growth of approximately 25.3%[25] - For the three months ended September 30, 2024, net income was 38.672million,comparedto30.994 million for the same period in 2023, representing a 24.5% increase[63] - The company reported a foreign currency translation adjustment of 17,089,000inQ32024,comparedto4,015,000 in Q3 2023[16] Assets and Liabilities - Total current assets increased to 1,445,314thousandasofSeptember30,2024,upfrom1,176,110 thousand at December 31, 2023, representing a growth of approximately 22.8%[13] - Total assets reached 1,794,175thousand,upfrom1,490,908 thousand, marking an increase of 20.4%[14] - Total liabilities grew to 725,092thousand,comparedto564,746 thousand, which is an increase of 28.4%[14] - Stockholders' equity increased to 888,166thousandfrom767,390 thousand, representing a growth of 15.7%[14] - Current liabilities totaled 610,035thousand,upfrom500,659 thousand, indicating a rise of 21.8%[14] - Long-term borrowings increased to 106,069thousandfrom53,952 thousand, reflecting a growth of 96.8%[14] Cash Flow and Investments - Cash provided by operating activities for the nine months ended September 30, 2024, was 63,855,000,comparedtocashusedinoperatingactivitiesof(36,970,000) for the same period in 2023[25] - The company had net cash provided by financing activities of 77,025,000fortheninemonthsendedSeptember30,2024,comparedto7,013,000 for the same period in 2023, indicating a substantial increase[26] - Cash, cash equivalents, and restricted cash at the end of the period on September 30, 2024, totaled 335,254,000,comparedto207,661,000 at the end of the same period in 2023, marking an increase of approximately 61.5%[27] - The company received net proceeds of RMB 22,478 (3,167)fromtheNuodeAssetFundduringthethreemonthsendedSeptember30,2024[116]Expenses−OperatingexpensesforQ32024totaled60,650,000, a 10% increase from 55,341,000inQ32023[16]−Researchanddevelopmentexpensesincreasedto27,837,000 in Q3 2024 from 26,151,000inQ32023,indicatinga640,792,000, significantly higher than 14,666,000forthesameperiodin2023,reflectinganincreaseofapproximately178.517,712,000 for the nine months ended September 30, 2024, compared to 11,235,000forthesameperiodin2023,reflectinganincreaseofapproximately57.7370,589 thousand, compared to 283,186thousandattheendof2023,indicatinga30.8628,720 thousand from 545,395thousand,reflectingagrowthof15.3628,720 thousand as of September 30, 2024, up from 545,395thousandatDecember31,2023,drivenbyariseinfinishedgoodsinventory[77]−Finishedgoodsinventoryvalueincreasedby70,030 thousand, reflecting higher first-tools under evaluation by customers[79] Shareholder Information - The weighted average shares of common stock outstanding for Q3 2024 were 62,500,903, compared to 60,219,218 in Q3 2023[16] - During the nine months ended September 30, 2024, ACM issued 1,488,347 shares of Class A common stock upon option exercises, compared to 919,448 shares for the same period in 2023, representing a 62% increase[128] - As of September 30, 2024, the number of shares of Class A common stock issued and outstanding was 57,524,519, up from 56,036,172 on December 31, 2023, marking an increase of 2.6%[129] Strategic Developments - The company emphasizes that its operations in mainland China are conducted without using a variable interest entity, ensuring compliance with local regulations[5] - ACM Shanghai completed the purchase of additional equity interest in Ninebell for 16,737,000onOctober21,2024,increasingitsownershipto36.47.75 million on October 1, 2024, aimed at expanding R&D and demonstration capabilities in the U.S. market[171] - ACM Research plans to offer up to 43.6 million ordinary shares in a private offering, which could generate gross proceeds of up to RMB 4.5 billion ($642.2 million) if fully consummated[189][190]